Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Researchers randomly assigned people with obesity (but not type 2 diabetes) to take either Zepbound or Wegovy for 72 weeks. All received weekly injections of the highest medication dose they could ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy.

Wegovy semaglutide injection pens. Credit ... cap the monthly copays for two popular weight-loss drugs, Wegovy and Zepbound, at $200. The impact on the employers' spending is unclear, but ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Eli Lilly launched its discounted self-pay option last summer with vials of Zepbound that patients have to draw and inject with syringes, instead of its typical auto-injector pen. The company ...

A coalition of more than 20 energy-intensive UK businesses met MPs in Westminster to make the case for a hydrogen mega-project which will inject £6.5bn into the economy and create 24,300 jobs across ...

countries will unlock immense potential for multilateral cooperation across sectors and inject stability into the world economy, analysts said ahead of an inaugural joint summit for the three parties.

For your first month of treatment, Reuters reports, you can nab a batch of Wegovy injections for $199 until June 30, Novo said. After that, it'll set you back $499 per month — which is still a ...

Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound in an expansion of the ways patients with a prescription can access the drug. The agreement means Ro has ...